GlaxoSmithkline is reportedly in talks to sell its Lucozade and Ribena drinks brands to Japan’s Suntory Beverage and Food.
Bloomberg News, citing unnamed sources, said agreement could be announced as early as September 9th, and the business could fetch more than stg£1 billion.
Introduced in 1927 and 1937 respectively, Lucozade and Ribena have annual sales of just over stg£500 million a year.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team